183 related articles for article (PubMed ID: 24293351)
1. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
2. PTEN loss and KRAS activation cooperate in murine biliary tract malignancies.
Marsh V; Davies EJ; Williams GT; Clarke AR
J Pathol; 2013 Jun; 230(2):165-73. PubMed ID: 23483557
[TBL] [Abstract][Full Text] [Related]
3. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA.
Xia RM; Liu T; Li WG; Xu XQ
Clin Transl Med; 2021 Oct; 11(10):e383. PubMed ID: 34709758
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-specific loss of PTEN results in colorectal juvenile polyp formation and invasive cancer.
Marsh Durban V; Jansen M; Davies EJ; Morsink FH; Offerhaus GJ; Clarke AR
Am J Pathol; 2014 Jan; 184(1):86-91. PubMed ID: 24200851
[TBL] [Abstract][Full Text] [Related]
6. TLR4 activates the β-catenin pathway to cause intestinal neoplasia.
Santaolalla R; Sussman DA; Ruiz JR; Davies JM; Pastorini C; España CL; Sotolongo J; Burlingame O; Bejarano PA; Philip S; Ahmed MM; Ko J; Dirisina R; Barrett TA; Shang L; Lira SA; Fukata M; Abreu MT
PLoS One; 2013; 8(5):e63298. PubMed ID: 23691015
[TBL] [Abstract][Full Text] [Related]
7. Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis.
Welz L; Kakavand N; Hang X; Laue G; Ito G; Silva MG; Plattner C; Mishra N; Tengen F; Ogris C; Jesinghaus M; Wottawa F; Arnold P; Kaikkonen L; Stengel S; Tran F; Das S; Kaser A; Trajanoski Z; Blumberg R; Roecken C; Saur D; Tschurtschenthaler M; Schreiber S; Rosenstiel P; Aden K
Gastroenterology; 2022 Jan; 162(1):223-237.e11. PubMed ID: 34599932
[TBL] [Abstract][Full Text] [Related]
8. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.
Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C
Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018
[TBL] [Abstract][Full Text] [Related]
9. Flat serrated adenomas of the colorectal mucosa.
Rubio CA; Jaramillo E
Jpn J Cancer Res; 1996 Mar; 87(3):305-9. PubMed ID: 8613434
[TBL] [Abstract][Full Text] [Related]
10. Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.
Richards JS; Fan HY; Liu Z; Tsoi M; Laguë MN; Boyer A; Boerboom D
Oncogene; 2012 Mar; 31(12):1504-20. PubMed ID: 21860425
[TBL] [Abstract][Full Text] [Related]
11. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Najumudeen AK; Ceteci F; Fey SK; Hamm G; Steven RT; Hall H; Nikula CJ; Dexter A; Murta T; Race AM; Sumpton D; Vlahov N; Gay DM; Knight JRP; Jackstadt R; Leach JDG; Ridgway RA; Johnson ER; Nixon C; Hedley A; Gilroy K; Clark W; Malla SB; Dunne PD; Rodriguez-Blanco G; Critchlow SE; Mrowinska A; Malviya G; Solovyev D; Brown G; Lewis DY; Mackay GM; Strathdee D; Tardito S; Gottlieb E; ; Takats Z; Barry ST; Goodwin RJA; Bunch J; Bushell M; Campbell AD; Sansom OJ
Nat Genet; 2021 Jan; 53(1):16-26. PubMed ID: 33414552
[TBL] [Abstract][Full Text] [Related]
12. Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer.
Maitra R; Thavornwatanayong T; Venkatesh MK; Chandy C; Vachss D; Augustine T; Guzik H; Koba W; Liu Q; Goel S
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766149
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice.
Foth M; Ahmad I; van Rhijn BW; van der Kwast T; Bergman AM; King L; Ridgway R; Leung HY; Fraser S; Sansom OJ; Iwata T
J Pathol; 2014 Jun; 233(2):148-58. PubMed ID: 24519156
[TBL] [Abstract][Full Text] [Related]
14. [
Liu J; Shen W; Cheng H; Fan M; Xiao J; Xu C; Tan J; Lai Y; Yu C; Sun D; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1452-1461. PubMed ID: 36329578
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Apc
Guo B; Zheng Y; Fan Y; Yang Y; Wang Y; Qin L; An Y; Xu X; Zhang X; Sun G; Dou H; Shao C; Gong Y; Jiang B; Hu H
Neoplasia; 2024 Jul; 53():101005. PubMed ID: 38761506
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target.
Vande Voorde J; Steven RT; Najumudeen AK; Ford CA; Dexter A; Gonzalez-Fernandez A; Nikula CJ; Xiang Y; Ford L; Maneta Stavrakaki S; Gilroy K; Zeiger LB; Pennel K; Hatthakarnkul P; Elia EA; Nasif A; Murta T; Manoli E; Mason S; Gillespie M; Lannagan TRM; Vlahov N; Ridgway RA; Nixon C; Raven A; Mills M; Athineos D; Kanellos G; Nourse C; Gay DM; Hughes M; Burton A; Yan B; Sellers K; Wu V; De Ridder K; Shokry E; Huerta Uribe A; Clark W; Clark G; Kirschner K; Thienpont B; Li VSW; Maddocks ODK; Barry ST; Goodwin RJA; Kinross J; Edwards J; Yuneva MO; Sumpton D; Takats Z; Campbell AD; Bunch J; Sansom OJ
Nat Metab; 2023 Aug; 5(8):1303-1318. PubMed ID: 37580540
[TBL] [Abstract][Full Text] [Related]
17. Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
[TBL] [Abstract][Full Text] [Related]
18. TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis.
Tsumuraya H; Okayama H; Katagata M; Matsuishi A; Fukai S; Ito M; Sakamoto W; Saito M; Momma T; Nakajima S; Mimura K; Kono K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731846
[TBL] [Abstract][Full Text] [Related]
19. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.
Jackstadt R; van Hooff SR; Leach JD; Cortes-Lavaud X; Lohuis JO; Ridgway RA; Wouters VM; Roper J; Kendall TJ; Roxburgh CS; Horgan PG; Nixon C; Nourse C; Gunzer M; Clark W; Hedley A; Yilmaz OH; Rashid M; Bailey P; Biankin AV; Campbell AD; Adams DJ; Barry ST; Steele CW; Medema JP; Sansom OJ
Cancer Cell; 2019 Sep; 36(3):319-336.e7. PubMed ID: 31526760
[TBL] [Abstract][Full Text] [Related]
20. KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.
Najumudeen AK; Fey SK; Millett LM; Ford CA; Gilroy K; Gunduz N; Ridgway RA; Anderson E; Strathdee D; Clark W; Nixon C; Morton JP; Campbell AD; Sansom OJ
Nat Commun; 2024 Jan; 15(1):100. PubMed ID: 38168062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
